Your browser doesn't support javascript.
loading
Novel SARS-CoV-2 Omicron variants in Istanbul; Rapid Preponderance of BA.2 and BA.5.
Tuyji-Tok, Yesim; Yücebag, Ebru; Keles, Ayse Betül; Kilinçarslan, Ayse Ceylan; Nohut, Okan Kadir; Salman-Yilmaz, Seda; Kuskucu, Mert Ahmet; Midilli, Kenan.
Afiliación
  • Tuyji-Tok Y; Department of Medical Microbiology, Istanbul University-Cerrahpasa School of Medicine, Istanbul, Turkey.
  • Yücebag E; Department of Medical Microbiology, Istanbul University-Cerrahpasa School of Medicine, Istanbul, Turkey.
  • Keles AB; Department of Medical Microbiology, Istanbul University-Cerrahpasa School of Medicine, Istanbul, Turkey.
  • Kilinçarslan AC; Department of Medical Microbiology, Istanbul University-Cerrahpasa School of Medicine, Istanbul, Turkey.
  • Nohut OK; Fikret Biyal Central Research Laboratory, Istanbul University-Cerrahpasa School of Medicine, Istanbul, Turkey.
  • Salman-Yilmaz S; Department of Forensic Medicine and Forensic Sciences, Istanbul University-Cerrahpasa School of Medicine, Istanbul, Turkey.
  • Kuskucu MA; Department of Medical Microbiology, Istanbul University-Cerrahpasa School of Medicine, Istanbul, Turkey.
  • Midilli K; Department of Medical Microbiology, Istanbul University-Cerrahpasa School of Medicine, Istanbul, Turkey.
Infect Dis Clin Microbiol ; 4(3): 192-198, 2022 Sep.
Article en En | MEDLINE | ID: mdl-38633395
ABSTRACT

Objective:

In Turkey, the fourth wave of SARS-CoV-2 started in December 2021 and peaked in mid-January 2022. Afterward, peaks were seen in the number of COVID-19 cases because of Omicron BA.2 and BA.5 variants. Our study aimed to observe the prevalence and viral load-related transmissibility rates of the Omicron BA.2 and BA.5 variant infections in our region between January 21 and July 01, 2022, using an easy and cost-effective PCR screening method.

Methods:

The frequency of BA.2 and BA.5 were determined by the two-stage allele-specific and drop-out RT-PCR method targeting NSP6 105-107del, spike 69-70del, and spike L452R mutation-specific primers. Transmissibility of the Omicron variants was assessed using cycle threshold (Ct) values (a proxy for SARS-CoV-2 viral load and infectivity). Also, using the next generation sequencing (NGS) method, existing mutations were analyzed by generating full-length sequences of the representative, randomly selected samples from the Omicron variants determined by PCR screening test.

Results:

We defined the first case of BA.2 on January 19, 2022, in Istanbul University-Cerrahpasa School of Medicine COVID-19 Molecular Diagnosis Laboratory. Following this, it was observed that BA.1 lost its dominance due to the increased transmissibility of BA.2. On May 5, we defined the first case of BA.5, and as of July this Omicron variant rapidly became preponderant, with a frequency of more than 85%. Compared with BA.1, BA.2 and BA.5 were associated with 2.82 (95% CI 2.33-4.12) and 2.49 (95% CI 2.16-3.55) fewer cycles, respectively, meaning higher transmissibility. As confirmed by the NGS results, it was concluded that screening with NSP6 105-107del, spike 69-70del and spike L452R mutation targeted PCR method, which is used uniquely in our hospital in Turkey, can be an easy and cost-effective method in the follow-up of Omicron variants.

Conclusion:

The higher viral load detection in infections with BA.2 and BA.5 reflects a prolonged disease period, and increased transmissibility, so rapid expansion of these Omicron variants in Turkey is inevitable. Even though the prevalence of the Omicron variants in the population can be monitored in near real-time by the PCR screening method, more sequencing studies are needed for the early identification of new mutations that will emerge.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Infect Dis Clin Microbiol Año: 2022 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Infect Dis Clin Microbiol Año: 2022 Tipo del documento: Article País de afiliación: Turquía